Literature DB >> 10572724

Analysis of fetal movements by Doppler actocardiogram and fetal B-mode imaging.

K Maeda1, M Tatsumura, M Utsu.   

Abstract

We have presented that fetal surveillance may be enhanced by use of the fetal actocardiogram and by computerized processing of fetal motion as well as fetal B-mode ultrasound imaging. Ultrasonic Doppler fetal actogram is a sensitive and objective method for detecting and recording fetal movements. Computer processing of the actograph output signals enables powerful, detailed, and convenient analysis of fetal physiologic phenomena. The actocardiogram is a useful measurement tool not only in fetal behavioral studies but also in evaluation of fetal well-being. It reduces false-positive, nonreactive NST and false-positive sinusoidal FHR pattern. It is a valuable tool to predict fetal distress. The results of intrapartum fetal monitoring are further improved by the antepartum application of the actocardiogram. Quantified fetal motion analysis is a useful, objective evaluation of the embryo and fetus. This method allows monitoring of changes in fetal movement, as well as frequency, amplitude, and duration. Furthermore, quantification of fetal motion enables evaluation of fetal behavior states and how these states relate to other measurements, such as changes in FHR. Numeric analysis of both fetal actogram and fetal motion from B-mode images is a promising application in the correlation of fetal activity or behavior with other fetal physiologic measurements.

Mesh:

Year:  1999        PMID: 10572724

Source DB:  PubMed          Journal:  Clin Perinatol        ISSN: 0095-5108            Impact factor:   3.430


  11 in total

1.  STUDIES IN FETAL BEHAVIOR: REVISITED, RENEWED, AND REIMAGINED.

Authors:  Janet A DiPietro; Kathleen A Costigan; Kristin M Voegtline
Journal:  Monogr Soc Res Child Dev       Date:  2015-09

2.  Prenatal antecedents of newborn neurological maturation.

Authors:  Janet A DiPietro; Katie T Kivlighan; Kathleen A Costigan; Suzanne E Rubin; Dorothy E Shiffler; Janice L Henderson; Joseph P Pillion
Journal:  Child Dev       Date:  2010 Jan-Feb

3.  Fetal responses to induced maternal relaxation during pregnancy.

Authors:  Janet A DiPietro; Kathleen A Costigan; Priscilla Nelson; Edith D Gurewitsch; Mark L Laudenslager
Journal:  Biol Psychol       Date:  2007-08-31       Impact factor: 3.251

Review 4.  Fetal effects of psychoactive drugs.

Authors:  Amy L Salisbury; Kathryn L Ponder; James F Padbury; Barry M Lester
Journal:  Clin Perinatol       Date:  2009-09       Impact factor: 3.430

5.  Physiological reactivity of pregnant women to evoked fetal startle.

Authors:  Janet A DiPietro; Kristin M Voegtline; Kathleen A Costigan; Frank Aguirre; Katie Kivlighan; Ping Chen
Journal:  J Psychosom Res       Date:  2013-08-05       Impact factor: 3.006

6.  Correlation between fetal brain activity patterns and behavioral states: an exploratory fetal magnetoencephalography study.

Authors:  Naim Haddad; Rathinaswamy B Govindan; Srinivasan Vairavan; Eric Siegel; Jessica Temple; Hubert Preissl; Curtis L Lowery; Hari Eswaran
Journal:  Exp Neurol       Date:  2011-01-13       Impact factor: 5.330

7.  Near-term fetal response to maternal spoken voice.

Authors:  Kristin M Voegtline; Kathleen A Costigan; Heather A Pater; Janet A DiPietro
Journal:  Infant Behav Dev       Date:  2013-06-07

8.  Prenatal origins of temperamental reactivity in early infancy.

Authors:  Janet A DiPietro; Melissa M Ghera; Kathleen A Costigan
Journal:  Early Hum Dev       Date:  2008-03-04       Impact factor: 2.079

9.  Fetal heart rate and motor activity associations with maternal organochlorine levels: results of an exploratory study.

Authors:  Janet A DiPietro; Meghan F Davis; Kathleen A Costigan; Dana Boyd Barr
Journal:  J Expo Sci Environ Epidemiol       Date:  2013-04-17       Impact factor: 5.563

10.  Fetal motor activity and maternal cortisol.

Authors:  Janet A DiPietro; Katie T Kivlighan; Kathleen A Costigan; Mark L Laudenslager
Journal:  Dev Psychobiol       Date:  2009-09       Impact factor: 3.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.